Latest debt-to-equity ratio
Jazz Pharmaceuticals Debt-to-equity ratio
Direct answer
Jazz Pharmaceuticals's debt-to-equity ratio is 91.83%.
The verified market snapshot reports 91.83%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free Jazz Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 91.83%
Explore related company data
View Jazz Pharmaceuticals's market capitalizationView Jazz Pharmaceuticals's p/e ratioView Jazz Pharmaceuticals's price-to-book ratioView Jazz Pharmaceuticals's return on equityView Jazz Pharmaceuticals's dividend yieldView Jazz Pharmaceuticals's 52-week price rangeView Jazz Pharmaceuticals's revenue growthView Jazz Pharmaceuticals's profit marginView all Jazz Pharmaceuticals key metricsReturn to Jazz Pharmaceuticals profile